Hopp til innhold

Valgte elementer er lagt i handlekurven

Gå til handlekurv
Artikkel

Publikasjonsliste for Nasjonalt vaksinasjonsregister SYSVAK

Oversikt over forskningsartikler der data fra Nasjonalt vaksinasjonsregister SYSVAK er brukt.

Colourbox.com
Colourbox.com

Hopp til innhold

Forskere og andre kan be om tilgang til statistikk eller data fra Nasjonalt vaksinasjonsregister SYSVAK og de andre helseregistrene som Folkehelseinstituttet er databehandlingsansvarlig for. Helseregistre er en unik kilde til kunnskap om befolkningens helse, årsaker til sykdom og kvaliteten på helse- og omsorgstjenestene.

Dette er en oversikt over artikler fra forskning hvor helseregistre er brukt som datakilde, publisert i vitenskapelige tidsskrift. Listene er basert på metodiske søk i internasjonale artikkeldatabaser. De vil kunne være ufullstendige, avhengig av hvordan kildeopplysningene er angitt i artiklene.

For å søke om tilgang til statistikk, data eller biologisk materiale fra helseregistre eller helseundersøkelser som Folkehelseinstituttet forvalter, må du benytte elektronisk søknadsskjema.

2017

Christiansen C, Bahmanyar S, Ghanima W, Kristensen N, Stryker S, Acquavella J, et al. NORDIC COUNTRY PATIENT REGISTRY FOR IMMUNE THROMBOCYTOPENIA (NCPRITP): A COHORT OF PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA IN DENMARK, SWEDEN, AND NORWAY. Haematologica 2017;102:587-.

Feiring B, Laake I, Bakken IJ, Greve-Isdahl M, Wyller VB, Haberg SE, et al. HPV vaccination and risk of chronic fatigue syndrome/myalgic encephalomyelitis: A nationwide register-based study from Norway. Vaccine 2017;35(33):4203-12.

Feiring B, Laake I, Trogstad L. No conflicting results in the article "HPV vaccination and risk of chronic fatigue syndrome/myalgic encephalomyelitis: A nationwide register-based study from Norway". Vaccine 2017;35(51):7082-3.

Ghaderi S, Stordal K, Gunnes N, Bakken IJ, Magnus P, Haberg SE. Encephalitis after influenza and vaccination: a nationwide population-based registry study from Norway. International Journal of Epidemiology 2017;46(5):1618-26.

Hagerup-Jenssen M, Kongsrud S, Riise OR. Suboptimal MMR2 vaccine coverage in six counties in Norway detected through the national immunisation registry, April 2014 to April 2017. Eurosurveillance 2017;22(17):39-44.

Irgens LM. Creation and growth of the medical birth registry; some observations and reflections from an old man with experience. Norsk Epidemiologi 2017;27(1-2):3-7.

Luxembourg A, Kjaer SK, Nygard M, Ellison MC, Group T, Marshall JB, et al. Design of a long-term follow-up effectiveness, immunogenicity and safety study of women who received the 9-valent human papillomavirus vaccine. Contemp Clin Trials 2017;52:54-61.

Mahic M, Mjaaland S, Bovelstad HM, Gunnes N, Susser E, Bresnahan M, et al. Maternal Immunoreactivity to Herpes Simplex Virus 2 and Risk of Autism Spectrum Disorder in Male Offspring. mSphere 2017;2(1):10.

Midtvedt K, Bergan S, Reisaeter AV, Vikse BE, Asberg A. Exposure to Mycophenolate and Fatherhood. Transplantation 2017;101(7):E214-E7.

Oakley L, Bakken IJ, Haberg SE. IS IN-UTERO EXPOSURE TO MATERNAL H1N1 INFLUENZA INFECTION AND VACCINATION ASSOCIATED WITH AN INCREASED RISK OF CHILDHOOD SEIZURES? A NORWEGIAN REGISTRY-BASED STUDY. Journal of Epidemiology and Community Health 2017;71:A2-A3.

Sriskandarajah S, Bostad L, Myklebust TA, Moller B, Skrede S, Bjorneklett R. Cancer in ANCA-Associated Glomerulonephritis: A Registry-Based Cohort Study. Int J Nephrol 2017:8.

2016

Bruun, T., Salamanca, B. V., Bekkevold, T., Vainio, K., Gibory, M., Haugstad, K. E., . . . Norwegian Enhanced Pediat, I. (2016). Burden of Rotavirus Disease in Norway Using National Registries for Public Health Research. Pediatric Infectious Disease Journal, 35(4), 396-400. doi:10.1097/inf.0000000000001055

Feiring, B., Laake, I., Molden, T., Haberg, S. E., Nokleby, H., Seterelv, S. S., . . . Trogstad, L. (2016). Do selective immunisation against tuberculosis and hepatitis B reach the targeted populations? A nationwide register-based study evaluating the recommendations in the Norwegian Childhood Immunisation Programme. Vaccine, 34(17), 2015-2020. doi:10.1016/j.vaccine.2016.02.060

Molden, T., Feiring, B., Ambur, O. H., Christiansen, I. K., Hansen, M., Laake, I., . . . Trogstad, L. (2016). Human papillomavirus prevalence and type distribution in urine samples from Norwegian women aged 17 and 21 years: A nationwide cross-sectional study of three non-vaccinated birth cohorts. Papillomavirus Research, 2, 153-158. doi:http://dx.doi.org/10.1016/j.pvr.2016.05.002

2015

Attramadal, C. G., Kumar, S., Boysen, M. E., Dhakal, H. P., Nesland, J. M., & Bryne, M. (2015). Tumor Budding, EMT and Cancer Stem Cells in T1-2/N0 Oral Squamous Cell Carcinomas. Anticancer Research, 35(11), 6111-6120.

Feiring, B., Laake, I., Molden, T., Cappelen, I., Haberg, S. E., Magnus, P., . . . Trogstad, L. (2015). Do parental education and income matter? A nationwide register-based study on HPV vaccine uptake in the school-based immunisation programme in Norway. Bmj Open, 5(5), 10.

Fiala, M., Terrando, N., & Dalli, J. (2015a). Specialized pro-resolving mediators from omega-3 fatty acids improve amyloid-beta phagocytosis and regulate inflammation in patients with minor cognitive impairment. Journal of Alzheimer's Disease, 48(2), 293-301.

Fiala, M., Terrando, N., & Dalli, J. (2015b). "Specialized pro-resolving mediators from omega-3 fatty acids improve amyloid-beta phagocytosis and regulate inflammation in patients with minor cognitive impairment": Erratum. Journal of Alzheimer's Disease, 49(4), 1191.

Hansen, B. T., Campbell, S., Burger, E., & Nygard, M. (2015). Correlates of HPV vaccine uptake in school-based routine vaccination of preadolescent girls in Norway: A register-based study of 90,000 girls and their parents. Preventive Medicine, 77, 4-10.

Magnus, P., Gunnes, N., Tveito, K., Bakken, I. J., Ghaderi, S., Stoltenberg, C., . . . Haberg, S. E. (2015). Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is associated with pandemic influenza infection, but not with an adjuvanted pandemic influenza vaccine. Vaccine, 33(46), 6173-6177.

Morken, N. H., Diaz-Garcia, C., Reisaeter, A. V., Foss, A., Leivestad, T., Geiran, O., . . . Brannstrom, M. (2015). Obstetric and Neonatal Outcome of Pregnancies Fathered by Males on Immunosuppression After Solid Organ Transplantation. American Journal of Transplantation, 15(6), 1666-1673.

Riise, O. R., Laake, I., Bergsaker, M. A., Nokleby, H., Haugen, I. L., & Storsaeter, J. (2015). Monitoring of timely and delayed vaccinations: a nation-wide registry-based study of Norwegian children aged<2 years. BMC Pediatrics, 15, 180.

Sriskandarajah, S., Aasarod, K., Skrede, S., Knoop, T., Reisaeter, A. V., & Bjorneklett, R. (2015). Improved prognosis in Norwegian patients with glomerulonephritis associated with anti-neutrophil cytoplasmic antibodies. Nephrology Dialysis Transplantation, 30, i67-i75.

2014

Barker, C. I. S., & Snape, M. D. (2014). Pandemic influenza A H1N1 vaccines and narcolepsy: Vaccine safety surveillance in action. The Lancet Infectious Diseases, 14(3), 227-238.

2013

Haberg, S. E., Trogstad, L., Gunnes, N., Wilcox, A. J., Gjessing, H. K., Samuelsen, S. O., . . . Stoltenberg, C. (2013). Risk of Fetal Death after Pandemic Influenza Virus Infection or Vaccination. New England Journal of Medicine, 368(4), 333-340.

Heier, M. S., Gautvik, K. M., Wannag, E., Bronder, K. H., Midtlyng, E., Kamaleri, Y., & Storsaeter, J. (2013). Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A. Sleep Medicine, 14(9), 867-871.

Holst, J., Oster, P., Arnold, R., Tatley, M. V., Naess, L. M., Aaberge, I. S., . . . Black, S. (2013). Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV) Lessons from past programs and implications for the future. Human Vaccines and Immunotherapeutics, 9(6), 1241-1253.

Nygard, M., Hansen, B. T., Dillner, J., Munk, C., Oddsson, K., Tryggvadottir, L., . . . Kjaer, S. K. (2014). Targeting Human Papillomavirus to Reduce the Burden of Cervical, Vulvar and Vaginal Cancer and Pre-Invasive Neoplasia: Establishing the Baseline for Surveillance. Plos One, 9(2), 9.

Steens, A., Bergsaker, M. A. R., Aaberge, I. S., Ronning, K., & Vestrheim, D. F. (2013). Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway. Vaccine, 31(52), 6232-6238.